Streptozotocin-induced diabetes differentially modifies haloperidol- and γ-hydroxybutyric acid (GHB)-induced catalepsy

Pharmacology, Toxicology and Pharmaceutical Science

• Rat 100%
• Diabetes Mellitus 83%
• Haloperidol 83%
• Catalepsy 66%
• Pyrazinamide 66%
• Behavioral Effect 33%
• Hydroxybutyric Acid 33%
• Dopamine 16%
• Receptor Antagonist 16%
• Dopamine Receptor 16%
• Dizocilpine 16%
• Dopamine Receptor Blocking Agent 16%
• Streptozotocin 16%
• Haloperidol-Induced Catalepsy 16%
• Streptozotocin-Induced Diabetes Mellitus 16%
• Dextro Aspartic Acid 16%
• Methyldienolone 16%

Neuroscience

• Haloperidol 83%
• Catalepsy 66%
• Diabetes 50%
• Streptozotocin 33%
• Dopamine 16%
• Receptor Antagonist 16%
• Dopamine Receptor 16%
• Methyldienolone 16%
• Dizocilpine 16%
• Haloperidol-Induced Catalepsy 16%
• Dextro Aspartic Acid 16%
• Receptor Binding 16%